JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Hydroxyurea (formerly known as NCI-c04831, NSC-32065; NCIc04831, NSC32065; Biosupressin; Carbamoyl oxime; Droxia; Hydroxycarbamide) is an approved antineoplastic drug that has been used for treating various cancers such as melanoma, sickle-cell disease and resistant chronic myelocytic leukemia. It acts as a cell apoptosis inducer by inhibiting DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxyurea can inhibit HIV-1 replication. In vitro experiments have shown that the 90% inhibitory concentration (IC90) of hydroxyurea for laboratory strains of HIV-1 in activated PBMC is 0.4 mM.
References: Clin Infect Dis. 2000 Jun; 30 Suppl 2:S193-7; Clin Infect Dis. 2000 Jun; 30 Suppl 2:S143-50.
Chemical Name: 1-hydroxyurea
InChi Key: VSNHCAURESNICA-UHFFFAOYSA-N
InChi Code: InChI=1S/CH4N2O2/c2-1(4)3-5/h5H, (H3, 2, 3, 4)
SMILES Code: O=C(N)NO
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!